MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Neuropsychiatric clusters in patients with Parkinson’s disease and their clinical and demographic correlates

M. Sommerauer, C. Schedlich-Teufer, P. Reker, E. Kalbe, J. Kessler, M. Barbe (Köln, Germany)

Meeting: 2019 International Congress

Abstract Number: 382

Keywords: Cognitive dysfunction, Depression, Obsessive-compulsive behavior/disorder

Session Information

Date: Monday, September 23, 2019

Session Title: Psychiatric Manifestations

Session Time: 1:45pm-3:15pm

Location: Les Muses Terrace, Level 3

Objective: To assess clusters of neuropsychiatric symptoms in Parkinson’s disease and their relation to motor symptoms and demographic markers in a large PD cohort.

Background: Neuropsychiatric symptoms are highly present in PD patients and might occur in specific clusters of symptoms. Characteristic motor phenotypes, medication regimes or social factors might prompt expression of specific clusters.

Method: Retrospective data analysis of 350 consecutive PD patients who underwent standardized neuropsychiatric work-up. From this cohort, 219 patients had complete assessment including assessment of depression and anxiety (HADS), impulse control disorders (QUIP), mania (MSS), and cognition (MMST), and were interrogated with hierarchal cluster analysis using the Ward-method. Resulting clusters were tested for differences in demographic, education and PD related factors including disease stage, UPDRS III in ON and OFF state, motor subtyping and type and amount of dopaminergic therapy using parametric and non-parametric tests as appropriate using SPSS version 25.

Results: We identified 4 clusters: 1) neuropsychiatricly unaffected (n = 59), 2) cognitively impaired (n = 24), 3) with impulse-control disorder (n = 45), and 4) patients with a mixed profile (“mixed”, n = 91). Neuropsychiatricly unaffected patients showed symptoms in none of the examined domains (p < 0.001); cognitively impaired patients exhibited lowest performance in MMST (24.3 ± 3.3, p < 0.001) and showed anxious (9.0 ± 2.7, p < 0.001 compared to cluster 1 and 4) and depressive symptoms (10.1 ± 2.8, p < 0.001). Patients with impulse-control disorder were characterized by high values in the QUIP (34.1 ± 13.0, p < 0.001) and anxious (9.5 ± 3.1, p < 0.001 compared to cluster 1 and 4) and depressive symptoms (7.3 ± 3.1, p < 0.001). Cognitively impaired patients tended to have more severe disease stage (3.3 ± 0.9 vs. 1) 2.7 ± 1.0 vs. 3) 2.6 ± 0.9 vs. 4) 2.5 ± 0.8, p = 0.54) and had lower education (p = 0,047). We did not find significant differences in other PD related factors between clusters.

Conclusion: PD patients´ neuropsychiatric profiles can be subtyped into different clusters. Anxiety and depression are common comorbid symptoms in patients with cognitive impairment and with impulse-control disorder. More severe disease stage (PD specific) and lower education (PD non-specific) are associated with cognitive impairment in PD.

To cite this abstract in AMA style:

M. Sommerauer, C. Schedlich-Teufer, P. Reker, E. Kalbe, J. Kessler, M. Barbe. Neuropsychiatric clusters in patients with Parkinson’s disease and their clinical and demographic correlates [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/neuropsychiatric-clusters-in-patients-with-parkinsons-disease-and-their-clinical-and-demographic-correlates/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/neuropsychiatric-clusters-in-patients-with-parkinsons-disease-and-their-clinical-and-demographic-correlates/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley